MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells

Yang,Yang; Li,Menghe; Chang,Su'e; Wang,Lumin; Song,Tusheng; Gao,Ling; Hu,Lili; Li,Zongfang; Liu,Liying; Yao,Jiayi; Huang,Chen

doi:10.3892/mmr.2014.2526

MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells

Authors:
- Yang Yang
- Menghe Li
- Su'e Chang
- Lumin Wang
- Tusheng Song
- Ling Gao
- Lili Hu
- Zongfang Li
- Liying Liu
- Jiayi Yao
- Chen Huang
View Affiliations

Affiliations: Department of Genetics and Molecular Biology, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710061, P.R. China, Engineering Research Center of Biotherapy and Translational Medicine of Shaanxi Province, Xi'an, Shaanxi 710061, P.R. China
Published online on: August 28, 2014 https://doi.org/10.3892/mmr.2014.2526
Pages: 2643-2648

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) are a class of small, non‑coding, endogenous RNAs that are important in tumor cell biological processes as they regulate gene expression. miR-195 has been demonstrated to be a tumor repressor in numerous types of human cancer. However, the mechanism by which miR‑195 suppresses tumor development remains to be elucidated. The aim of this study was to investigate the effect of miR-195 on the biological functions of HepG2 hepatocellular carcinoma (HCC) cells and identify the association between miR-195 and Wnt3a in HCC. miR-195 mRNA expression levels in HCC tissues and cell lines were measured by reverse transcription polymerase chain reaction analysis. miR-195 function was measured with cell proliferation, cell cycle and apoptosis assays following transfection with miR‑195 and anti‑miR‑195 sequences, and the respective controls. Luciferase reporter assay was used to determine whether Wnt3a was a target of miR-195. In addition, Wnt3a expression levels were determined in HCC cells using western blot analysis. The miR-195 expression levels were found to be reduced in HCC tissues and cell lines. miR-195 overexpression resulted in a reduction in cell proliferation. In addition, the overexpression of miR-195 in HCC cells induced G1 phase cell cycle arrest and promoted apoptosis. Furthermore, Wnt3a was demonstrated to be directly targeted by miR-195. These findings suggest that miR-195 is key in regulating cell proliferation, cell cycle and apoptosis through targeting Wnt3a. In addition, overexpression of miR-195 may be a potential therapeutic strategy in the treatment of HCC.

View Figures

View References

1	Roberts LR: Sorafenib in liver cancer - just the beginning. N Engl J Med. 359:420–422. 2008. View Article : Google Scholar : PubMed/NCBI
2	Yamashita T and Wang XW: Cancer stem cells in the develop ment of liver cancer. J Clin Invest. 123:1911–1918. 2013. View Article : Google Scholar
3	Nordenstedt H, White DL and El-Serag HB: The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 42(Suppl 3): S206–S214. 2010. View Article : Google Scholar : PubMed/NCBI
4	McGlynn KA and London WT: The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis. 15:223–243. 2011. View Article : Google Scholar : PubMed/NCBI
5	Long XH, Mao JH, Peng AF, et al: Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med. 5:1048–1052. 2013.PubMed/NCBI
6	Hiyoshi Y, Kamohara H, Karashima R, et al: MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922. 2009. View Article : Google Scholar : PubMed/NCBI
7	Moriyama T, Ohuchida K, Mizumoto K, et al: MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 8:1067–1074. 2009. View Article : Google Scholar
8	Chen D, Zhang Y, Wang J, et al: MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117⁺CD44⁺ ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J Ovarian Res. 6:502013. View Article : Google Scholar : PubMed/NCBI
9	Coulouarn C, Factor VM, Andersen JB, Durkin ME and Thorgeirsson SS: Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 28:3526–3536. 2009. View Article : Google Scholar : PubMed/NCBI
10	Liang L, Wong CM, Ying Q, et al: MicroRNA-125b suppressed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology. 52:1731–1740. 2010. View Article : Google Scholar : PubMed/NCBI
11	Liu AM, Poon RT and Luk JM: MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Comm. 394:623–627. 2010. View Article : Google Scholar : PubMed/NCBI
12	Meng F, Henson R, Wehbe-Janek H, et al: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
13	Su H, Yang JR, Xu T, et al: MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
14	Zhang J, Luo N, Luo Y, et al: microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol. 40:747–756. 2012.PubMed/NCBI
15	Ichimi T, Enokida H, Okuno Y, et al: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. International Journal of Cancer. 125:345–352. 2009. View Article : Google Scholar : PubMed/NCBI
16	Soon PSH, Tacon LJ, Gill AJ, et al: miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res. 15:7684–7692. 2009. View Article : Google Scholar : PubMed/NCBI
17	Li D, Zhao Y, Liu C, et al: Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
18	Guo J, Miao Y, Xiao B, et al: Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 24:652–657. 2009. View Article : Google Scholar
19	Cadigan KM and Nusse R: Wnt signaling: a common theme in animal development. Genes Dev. 11:3286–3305. 1997. View Article : Google Scholar : PubMed/NCBI
20	Majid S, Dar AA, Saini S, et al: MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PloS One. 8:e676862013. View Article : Google Scholar : PubMed/NCBI
21	Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006. View Article : Google Scholar : PubMed/NCBI
22	Hui W, Yuntao L, Lun L, et al: MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PloS One. 8:e549322013. View Article : Google Scholar : PubMed/NCBI
23	Liu L, Chen L, Xu Y, Li R and Du X: microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun. 400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
24	Fatima S, Lee NP and Luk JM: Dickkopfs and Wnt/β-catenin signalling in liver cancer. World J Clin Oncol. 2:311–325. 2011.
25	Calvisi DF, Wang C, Ho C, et al: Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology. 140:1071–1083. 2011. View Article : Google Scholar
26	Caja L, Sancho P, Bertran E, et al: Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-β-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res. 69:7595–7602. 2009.PubMed/NCBI
27	Chang Q, Zhang Y, Beezhold KJ, et al: Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. J Hepatol. 50:323–333. 2009. View Article : Google Scholar : PubMed/NCBI
28	He Y, Zhang H, Yin J, et al: IκBα gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis. 30:1916–1922. 2009.
29	Whittaker S, Marais R and Zhu A: The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 29:4989–5005. 2010. View Article : Google Scholar : PubMed/NCBI
30	Lu D, Zhao Y, Tawatao R, et al: Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 101:3118–3123. 2004. View Article : Google Scholar : PubMed/NCBI
31	Ilyas M: Wnt signalling and the mechanistic basis of tumour development. J Pathol. 205:130–144. 2005. View Article : Google Scholar : PubMed/NCBI
32	Nusse R and Varmus HE: Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 31:99–109. 1982. View Article : Google Scholar : PubMed/NCBI
33	Gougelet A and Colnot S: A Complex Interplay between Wnt/β-Catenin Signalling and the Cell Cycle in the Adult Liver. Int J Hepatol. 2012:8161252012.
34	He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
35	Shtutman M, Zhurinsky J, Simcha I, et al: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 96:5522–5527. 1999.
36	Tetsu O and McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422–426. 1999.
37	Kaur P, Mani S, Cros MP, et al: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma. Tumor Biol. 33:325–336. 2012. View Article : Google Scholar : PubMed/NCBI
38	Guan CN, Chen XM, Lou HQ, et al: Clinical Significance of Axin and β-catenin Protein Expression in Primary Hepatocellular Carcinomas. Asian Pac J Cancer Prev. 13:677–681. 2012.
39	Loeppen S, Koehle C, Buchmann A and Schwarz M: A β-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors. Carcinogenesis. 26:239–248. 2005.
40	Tien LT, Ito M, Nakao M, et al: Expression of β-catenin in hepato-cellular carcinoma. World J Gastroenterol. 11:2398–2401. 2005.